Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Here Are All The Big Biotech Mergers In 2016
Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
Bert's August Stock Watch List (Seeking Alpha)
Related LNKD
What TD Ameritrade's IMX Tracker Can Do For Investors, And What It's Been Telling Us
July's Recovery Triggered Selling Activity In A Few Big Names
Bill Nygren's Top Performers (GuruFocus)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Aug 2016JefferiesMaintainsBuy
Jul 2016JefferiesMaintainsBuy
Jun 2016JefferiesMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!